雅培
ABT106.090USD
+0.040+0.04%
收盘 01/29, 16:00（美东）报价延迟15分钟
184.48B总市值
28.44市盈率 TTM
关于 雅培 公司
雅培是一家横跨全球的医疗保健领导者，专注于多元健康产品的研发、制造与销售，业务框架涵盖四大单元：成熟药品、诊断、营养以及医疗器械。成熟药品单元负责多品牌仿制药的国际行销；诊断单元向血库、医院、商业实验室与替代护理点提供检测系统与试剂；营养单元经营成人及儿童营养品全球通路；医疗器械单元销售节律管理、电生理、心衰、血管、结构心脏、神经调控及糖尿病护理装置，持续推动创新改善患者生命品质。其全球供应链覆盖六大洲，利用数据分析与可持续制造提升效率与品质保障。
雅培简介
公司代码ABT
公司名称Abbott Laboratories
上市日期Apr 06, 2073
CEOFord (Robert B)
员工数量114000
证券类型Ordinary Share
年结日Apr 06
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编60064-3500
电话12246676100
网址https://www.abbott.com
公司代码ABT
上市日期Apr 06, 2073
CEOFord (Robert B)
雅培公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+1635.00%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
132.23K
-1536.00%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-791.00%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-269.00%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-387.00%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+1635.00%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-965.00%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
19.03K
+1635.00%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
15.71K
+1635.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+1635.00%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
132.23K
-1536.00%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-791.00%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-269.00%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-387.00%
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Diabetes Care
2.06B
18.09%
Core Laboratory
1.36B
12.00%
Structural Heart
1.28B
11.23%
Adult Nutritionals
1.18B
10.34%
Key Emerging Markets
1.10B
9.65%
其他
4.40B
38.68%
地区USD
名称
营收
占比
All other Countries
7.07B
62.19%
United States
4.30B
37.81%
业务
地区
业务USD
名称
营收
占比
Diabetes Care
2.06B
18.09%
Core Laboratory
1.36B
12.00%
Structural Heart
1.28B
11.23%
Adult Nutritionals
1.18B
10.34%
Key Emerging Markets
1.10B
9.65%
其他
4.40B
38.68%
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
10.05%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Investment Management (US)
4.50%
Capital International Investors
3.54%
Capital Research Global Investors
2.23%
其他
74.55%
持股股东
持股股东
占比
The Vanguard Group, Inc.
10.05%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Investment Management (US)
4.50%
Capital International Investors
3.54%
Capital Research Global Investors
2.23%
其他
74.55%
股东类型
持股股东
占比
Investment Advisor
47.26%
Investment Advisor/Hedge Fund
23.11%
Research Firm
3.51%
Pension Fund
2.34%
Bank and Trust
2.20%
Sovereign Wealth Fund
1.37%
Insurance Company
1.02%
Hedge Fund
0.49%
Individual Investor
0.48%
其他
18.22%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
4606
1.42B
81.82%
+3.92M
2025Q3
4681
1.42B
81.87%
+8.53M
2025Q2
4668
1.41B
81.51%
+6.23M
2025Q1
4636
1.40B
80.10%
+7.18M
2024Q4
4554
1.38B
78.81%
+33.68M
2024Q3
4367
1.35B
78.83%
-5.95M
2024Q2
4376
1.35B
78.36%
+5.03M
2024Q1
4375
1.35B
77.56%
-1.86M
2023Q4
4400
1.34B
77.62%
+7.10M
2023Q3
4258
1.33B
78.26%
-4.16M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
174.89M
10.06%
+2.54M
+1.47%
Nov 28, 2025
BlackRock Institutional Trust Company, N.A.
89.23M
5.13%
+711.43K
+0.80%
Sep 30, 2025
State Street Investment Management (US)
78.23M
4.5%
-128.28K
-0.16%
Sep 30, 2025
Capital International Investors
61.61M
3.54%
+1.48M
+2.46%
Sep 30, 2025
Capital Research Global Investors
38.77M
2.23%
-3.00M
-7.18%
Sep 30, 2025
Geode Capital Management, L.L.C.
38.54M
2.22%
+248.83K
+0.65%
Sep 30, 2025
Wellington Management Company, LLP
23.25M
1.34%
-1.80M
-7.20%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
22.25M
1.28%
+1.27M
+6.03%
Jun 30, 2025
JP Morgan Asset Management
19.25M
1.11%
-7.14M
-27.05%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
17.77M
1.02%
+9.40M
+112.38%
Sep 30, 2025
查看更多
持股ETF
更新时间: 11月5日 周三
更新时间: 11月5日 周三
机构名称
占比
iShares U.S. Medical Devices ETF
19.31%
Goldman Sachs Future Health Care Equity ETF
6.26%
SMI 3Fourteen Full-Cycle Trend ETF
5.01%
Invesco Pharmaceuticals ETF
4.99%
Health Care Select Sector SPDR Fund
4.62%
Proshares Ultra Health Care
4.61%
Tema Heart & Health ETF
4.5%
iShares U.S. Healthcare ETF
4.42%
AdvisorShares Focused Equity ETF
4.37%
Polen Capital Global Growth ETF
4.27%
查看更多
iShares U.S. Medical Devices ETF
占比19.31%
Goldman Sachs Future Health Care Equity ETF
占比6.26%
SMI 3Fourteen Full-Cycle Trend ETF
占比5.01%
Invesco Pharmaceuticals ETF
占比4.99%
Health Care Select Sector SPDR Fund
占比4.62%
Proshares Ultra Health Care
占比4.61%
Tema Heart & Health ETF
占比4.5%
iShares U.S. Healthcare ETF
占比4.42%
AdvisorShares Focused Equity ETF
占比4.37%
Polen Capital Global Growth ETF
占比4.27%
分红派息
近5年累计派现
13.90B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 12, 2025
ABT.NB Final Cash Dividend of gross USD 0.63 paid on Feb 13, 2026 going ex on Jan 15, 2026 with reinvestment option
Jan 15, 2026
Feb 13, 2026
Jan 15, 2026
Sep 19, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Nov 17, 2025 going ex on Oct 15, 2025 with reinvestment option
Oct 15, 2025
Nov 17, 2025
Oct 15, 2025
Jun 13, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Aug 15, 2025 going ex on Jul 15, 2025 with reinvestment option
Jul 15, 2025
Aug 15, 2025
Jul 15, 2025
Feb 21, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on May 15, 2025 going ex on Apr 15, 2025 with reinvestment option
Apr 15, 2025
May 15, 2025
Apr 15, 2025
Dec 13, 2024
ABT.NB Final Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
查看更多
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
